REGISTERED
on 27 Dec 2022
Last Applicant/ Owned by
Ringaskiddy
IE
Serial Number
79331573 filed on 07th May 2021
Registration Number
6932819 registered on 27th Dec 2022
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
ASD - HIPROS
Development of pharmaceutical products and drug products; research on pharmaceutical products and drug products; research and development of new products in the pharmaceutical industry; Consulting services in the field of design and development of engineering processes for the pharmaceutical industry; research in the field of optimizing of manufacturing processes for the pharmaceutical industry A Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Development of pharmaceutical products and drug products; research on pharmaceutical products and drug products; research and development of new products in the pharmaceutical industry; Consulting services in the field of design and development of engineering processes for the pharmaceutical industry; research in the field of optimizing of manufacturing processes for the pharmaceutical industry
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Active pharmaceutical ingredients in the nature of pharmaceutical preparations, which are used for the prevention and treatment of disorders of the skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems of humans or animals; compositions for medical and veterinarian use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; medical diagnostic compositions, namely medical diagnostic reagents; chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79331573
Mark Type
No Service Mark
Attorney Docket Number
No TM10700US00
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th May 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 14th Apr 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| 13th Apr 2023 | FINAL DISPOSITION PROCESSED |
| 27th Mar 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 12th Feb 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| 27th Dec 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 27th Dec 2022 | REGISTERED-PRINCIPAL REGISTER |
| 11th Oct 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 11th Oct 2022 | PUBLISHED FOR OPPOSITION |
| 10th Oct 2022 | NOTIFICATION PROCESSED BY IB |